Clinical Lead (Executive Dir., Senior Dir. or Director)

US (Remote)
Role Details
Position
Clinical Lead
Function
Clinical
Location
US (Remote)
Reports To
VP Clinical Lead

About the Job

The Clinical Lead (Executive Director, Senior Director or Director) is a clinical development leader accountable for advancing Ailux’s immunology pipeline from first-in-human through Ph1b proof-of-medicine (PoM) and proof-of-concept (PoC) trials, with scope to continue into later-stage development.

Acting as Clinical Lead and, where appropriate, Study-Responsible Physician, this leader will integrate clinical, translational, biomarker, disease-biology, and pathway strategies across IND/CTA-enabling development, FIH Phase 1, Phase 1b PoM, and Phase 2a PoC studies, with scope to continue into later-stage development.

The role provides end-to-end program and study leadership—from translational planning and protocol design through execution, medical monitoring, data analysis, interpretation, and communication of results.

In close partnership with Clinical Scientists, the Clinical Lead will coordinate cross-functional teams, translate therapeutic-area, disease, pathway, Target Product Profile, and value-creation strategies into executable plans, and deliver governance-approved milestones within timeline and budget commitments.

The Clinical Lead will connect Discovery Research, Translational Science, Biomarkers, and later-stage Clinical Development while partnering closely with Clinical Operations, Clinical Pharmacology, Regulatory, CMC, Safety, DMPK, Biomarkers, Project Management, Finance, and Business Development. The role also requires strong collaboration with Clinical Scientists, investigators, academic translational centers, external experts, contract research organizations (CROs), and development partners.

Reporting to the VP Clinical Lead, this individual will support program representation at governance meetings and external forums.

Key Responsibilities

Team & Organizational Leadership

  • Serve as an integral member of inclusive, high-performing program and study teams, working through influence while maintaining clear clinical accountability.
  • Establish effective ways of working with Clinical Scientists and functional partners, with transparent decisions, constructive scientific challenge, timely escalation, and disciplined execution.
  • Coach and develop team members in integrated drug development, evidence generation, and decision-making.
  • Strengthen Ailux’s clinical development, governance, and translational capabilities as the portfolio expands.
  • Promote a patient-focused, data-driven, learning-oriented culture grounded in scientific integrity, quality, and ethical drug development.

Clinical Development Strategy & Leadership

  • Develop and execute integrated global clinical development and translational plans from preclinical to FIH, Phase 1, Phase 1b PoM, and Phase 2a PoC, maintaining a credible path to later-stage development.
  • Integrate disease biology, pathway hypotheses, biomarkers, patient segmentation, PK/PD, target engagement, dose, schedule, cohort, endpoint, and benefit-risk strategies into clinically meaningful plans.
  • Lead cross-functional program and trial teams in close partnership with Clinical Scientists, establishing clear objectives, roles, decision criteria, timelines, budgets, risks, and escalation pathways.
  • Represent Clinical Development on early clinical development plans (CDPs), project, portfolio, and governance teams, translating emerging evidence into clear investment and development recommendations.
  • Champion focused adaptive, basket, platform, decentralized, digital, and patient-centric approaches where scientifically and operationally appropriate.

Pre-clinical Development & Transition to Clinic

  • Lead candidate-to-clinic planning from development-candidate selection through IND/CTA clearance and FIH initiation, coordinating nonclinical, biomarker, manufacturing, regulatory, and clinical readiness.
  • Partner with Translational Science, Biomarkers, Clinical Scientists, pharmacology, DMPK, toxicology, safety, bioanalysis, CMC, Quality, Clinical Development, and Regulatory to translate pharmacology and exposure-response data into dose, escalation, schedule, biomarker, PK/PD, patient-selection, and PoM/PoC strategies.
  • Engage investigators, external KOL experts, and academic translational sites to optimize translational strategy, experimental medicine plans, study feasibility, and recruitment.
  • Lead clinical components of global IND/CTA submissions, health-authority interactions, and FIH readiness, including protocol design, eligibility criteria, endpoints, safety governance, dose escalation, medical monitoring, and data-review plans.
  • Ensure CMC and clinical-supply readiness and manage nonclinical, CMC, regulatory, safety, and development risks in accordance with GLP, GMP, GCP, ethical, and data-integrity standards.

Clinical Development & Proof of Concept

  • Function as Clinical Lead and, where appropriate, Study-Responsible Physician, for Phase 1, Phase 1b PoM, and Phase 2a PoC trials, with scope to continue into later-stage development.
  • In close partnership with Clinical Operations and Clinical Scientists, own studies end to end—from protocol concept and authoring through operational execution, enrollment, medical monitoring, data review, analysis, interpretation, and reporting.
  • Design feasible studies that test key hypotheses and generate decision-quality evidence on safety, tolerability, PK/PD, target engagement, biological activity, patient stratification, and PoM/PoC clinical benefit.
  • Integrate emerging clinical, translational, biomarker, pharmacology, pharmacodynamics, and safety data to adapt dose, schedule, cohorts, indications, endpoints, and expansion decisions.
  • Ensure protocol integrity, participant safety, high-quality global trial conduct, and compliance with ICH-GCP, regulatory, and internal quality requirements.

Communication & Stakeholder Management

  • Prepare and present evidence-based strategies, results, investment proposals, and recommendations to the VP Clinical Lead, project and portfolio teams, governance bodies, and scientific audiences.
  • In close partnership with Clinical Scientists, prepare, direct, and review protocols, clinical study reports, translational plans, Investigator’s Brochures, IND/CTA content, abstracts, manuscripts, and technical reports.
  • Serve as the cross-functional clinical and translational spokesperson for assigned programs and lead or participate in scientific, safety, and other cross-functional review groups.

Qualifications, Education & Experience

Essential

  • MD or MD-PhD degree, or equivalent medical qualification, required; training and scientific depth in immunology, inflammation, immune-mediated diseases, or a related discipline strongly preferred.
  • 3-5+ years of relevant biotechnology, pharmaceutical, and/or translational research experience, including leadership of early-phase global trials and matrix clinical, translational, or research teams.
  • Demonstrated expertise progressing programs from pre-clinical development through FIH, Phase 1 experimental medicine, Phase 1b PoM, and Phase 2a PoC, with a record of rigorous study design and delivery.
  • Broad understanding of translational medicine, biomarkers, nonclinical and clinical development, regulatory strategy, CMC, safety, DMPK/clinical pharmacology, pharmacodynamics/biomarkers, global regulatory requirements, and ICH-GCP.
  • Ability to develop integrated strategies, identify value drivers and risks, interpret complex data, and make clear clinical, governance, and investment recommendations.
  • Strong strategic thinking, execution, prioritization, problem-solving, communication, influencing, collaboration, and people-leadership skills in fast-moving, evolving organizations.
  • Willingness and ability to travel, including trans-Atlantic travel, up to approximately 10%.
  • Commitment to participant safety, scientific integrity, quality, and ethical drug development.

Leadership Profile

  • The successful candidate combines scientific depth, strategic judgment, clinical leadership, and executional discipline. Collaborative but decisive, they can move between detailed program data and portfolio priorities, lead senior experts without relying on hierarchy, work closely with Clinical Scientists, and make rigorous decisions under uncertainty. They will connect pre-clinical, translational, and clinical development to advance differentiated medicines efficiently and responsibly.

Preferred Qualifications

  • Experience in immunological diseases, experimental medicine, and progression of programs through clinical PoM/PoC into later-stage development.
  • Experience with IND/CTA submissions, global health-authority interactions, and development teams spanning the U.S., Europe and China.
  • Experience with innovative immune cell-based or biologic therapies, including antibodies and multispecifics; T-cell engager experience is of interest but not required.
  • Strong publication record and experience with external partnerships, licensing, due diligence, or alliance management.
  • Experience operating successfully in a growing biotechnology company.

Skills & Competencies

Additional Information

The Company

Ailux is an innovative biotechnology company focused on discovering and developing next-generation biologic therapeutics for immunological diseases with high unmet medical need. The company integrates advanced computational approaches with rigorous experimental, translational, and clinical science across the drug discovery and development continuum, enabling faster and more informed decision-making from target identification through clinical development.

As an AI-native biotech and wholly owned subsidiary of XtalPi, Ailux combines proprietary computational models with state-of-the-art wet lab capabilities to design differentiated therapeutics against challenging biological targets. The company has established strategic partnerships with leading pharmaceutical organizations, providing external validation of its scientific platform and discovery capabilities.

Ailux’s vision is to build a fully integrated, end-to-end drug discovery and development organization capable of delivering the next generation of medicines for patients with chronic immunological diseases.

Backed by an experienced leadership team, leading scientific advisors, and a highly multidisciplinary organization, Ailux is approaching a key inflection point as its first wave of therapeutic programs advances toward clinical development. This is an opportunity to play a central role in leading programs from pre-clinical development into the clinic and through clinical proof-of-concept, shaping the pipeline and development culture of a rapidly growing biotechnology company.

Ideal Candidate Profile